Prevention of methicillin-resistant Staphylococcus aureus infection: Is Europe winning the fight?

Infection Control and Hospital Epidemiology

Volumn 31, Issue SUPPL. 1, 2010, Pages

  Struelens, Marc J ^a   Monnet, Dominique L ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CONFERENCE PAPER; EUROPE; HEALTH CARE; HEALTH PROMOTION; HUMAN; HYGIENE; INCIDENCE; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NETHERLANDS; NONHUMAN; SCANDINAVIA; STAPHYLOCOCCUS INFECTION;

COMMUNICABLE DISEASE CONTROL; EUROPE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 78449263231     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/655997     Document Type: Conference Paper

References (10)

1. European Antimicrobial Resistance Surveillance System (EARSS). EARSS annual report 2008: on-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. 2009.
2. European Centre for Disease Prevention and Control (ECDC)/European Medicines Agency (EMEA) Joint Working Group. Technical report. The bacterial challenge: time to react. A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents. Stockholm: European Centre for Disease Prevention and Control; 2009:1-54. http://ecdc.europa.eu/en/publications/ Publications/0909-TER-The-Bacterial- Challenge-Time-to-React.pdf. Accessed April 22, 2010.
3. Bartels MD, Kristoffersen K, Boye K, Westh H. Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy. Clin Microbiol Infect 2010;16(1):78-83.
4. Grundmann H, Aanensen DM, van den Wijngaard CC, et al; European Staphylococcal Reference Laboratory Working Group. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 2010;7(1):e1000215.
5. Mears A, White A, Cookson B, et al. Healthcare-associated infection in acute hospitals: which interventions are effective? J Hosp Infect 2009;71(4):307-313.
6. Carlet J, Astagneau P, Brun-Buisson C, et al. French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009;30(8):737-745.
7. Goossens H, Coenen S, Costers M, et al. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill 2008;13(46):19036
8. Grammatico-Guillon L, Thiolet JM, Bernillon P, Coignard B, Khoshnood B, Desenclos JC. Relationship between the prevalence of methicillinresistant Staphylococcus aureus infection and indicators of nosocomial infection control measures: a population-based study in French hospitals. Infect Control Hosp Epidemiol 2009;30(9):861-869.
9. MacKenzie FM, Bruce J, Struelens MJ, et al; ARPAC Steering Group. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. Clin Microbiol Infect 2007;13(3):269-276. (Pubitemid 46603357)
10. van Loo I, Huijsdens X, Tiemersma E, et al. Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis 2007;13(12):1834-1839. (Pubitemid 350248483)